Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.2B | 13.5B | 14.1B | 13.5B |
| Cost of revenue | 10.5B | 10.7B | 11.1B | 10.6B |
| Gross profit | 2.7B | 2.8B | 3.0B | 2.9B |
| Operating expense | ||||
| Research & development | 401M | 397M | 392M | 413M |
| Selling general and admin | 1.5B | 1.5B | 1.4B | 1.4B |
| Other operating expenses | — | — | — | — |
| Operating income | 793M | 921M | 1.1B | 1.0B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 146M | 141M | 147M | 149M |
| Other income expense | -141M | -76M | -115M | -32M |
| Pretax income | 506M | 704M | 862M | 827M |
| Tax provision | 100M | 139M | -44M | 187M |
| Net income | 406M | 565M | 906M | 640M |
| Basic EPS | 0.4 | 0.6 | 0.9 | 0.7 |
| Diluted EPS | 0.4 | 0.6 | 0.9 | 0.7 |
| Basic average shares | 950M | 948M | 959M | 979M |
| Diluted average shares | 956M | 957M | 971M | 990M |
| EBITDA | 996M | 1.1B | 1.4B | 1.3B |
| Net income from continuing op. | 406M | 565M | 906M | 640M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |